US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

3.010
+0.040+1.35%

Close Aug 23 16:00 ET

3.010
0.0000.00%

Post 20:01 ET

127.76MMarket Cap-1846P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Repare Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 3.200M	--
--	2024/Q3	-- / 2.914M	--
--	2024/Q2	1.073M / 2.929M	--
--	2024/Q1	52.404M / 38.400M	--
--	2023/Q4	13.047M / 18.931M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 3.200M--

--2024/Q3-- / 2.914M--

--2024/Q21.073M / 2.929M--

--2024/Q152.404M / 38.400M--

--2023/Q413.047M / 18.931M--

Unlock Free Earnings Estimates

Open Account

Repare Therapeutics Earnings Reports

Repare Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 16:24 ET

Repare Therapeutics | 10-Q: Q1 2024 Earnings Report

May 7 16:22 ET

Repare Therapeutics | 10-K: FY2023 Annual Report

Feb 28 07:17 ET

Repare Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 07:10 ET

Analyst Rating

Updated: Aug 19, 2024

Strong Buy

Buy
77.78%
Hold
22.22%
Sell
0.00%

Price Target

No Data

Heat List

Overall